If the page does not redirect, click here
New knowledge on EphB signaling may improve treatment of intestinal cancers
A new study led by researchers at Sweden's Karolinska Institutet and Nanyang Technological University in Singapore, provides experimental evidence that a drug that inhibits the EphB-signaling pathway in the cell effectively can suppress the development of intestinal tumors. According to the investigators, this knowledge may be important in the design of new treatments for abrogating adenoma formation and cancer progression in patients predisposed to develop colorectal cancer.Ads from Inoreader:Remove ads • Advertise with Inoreader